Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/IRLAB-THERAPEUTICS-AB-61747292/nieuws/IRLAB-krijgt-een-einde-fase-2-bijeenkomst-met-de-FDA-voor-het-fase-III-klare-mesdopetam-programma-45663674/?utm_source=whatsapp&utm_medium=social&utm_campaign=share